Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sehür Sibel Özkaynak"'
Autor:
Seda Ocana-Insuasty, Nuriye Oz, Hamit Selim Karabekir, Merve Yildirim, Kamil Karaali, Sehur Sibel Ozkaynak, Nigar Keles-Celik
Publikováno v:
Medicine Science, Vol 13, Iss 3, Pp 512-8 (2024)
Parkinson's disease (PD) is the most common neurodegenerative disease after Alzheimer's disease. PD causes degenerative changes in the cerebellum. It is known that the cerebellum does not have a symmetrical anatomy and some pathological disorders may
Externí odkaz:
https://doaj.org/article/444b9edb4cdd4e0897ad6aacdbbc809e
Autor:
Gökçe Yağmur Güneş Gencer, Nazan Şimşek Erdem, Lutfiye Ipek, Sehur Sibel Özkaynak, Tanju Uçar
Publikováno v:
Annals of Indian Academy of Neurology, Vol 26, Iss 4, Pp 530-536 (2023)
Objective: This study aimed to identify caregiver burden (CB) and contributing factors to CB for Parkinson's disease (PD) patients under Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) treatment, and investigation the factors, affecting the care
Externí odkaz:
https://doaj.org/article/c851ceb91cf34947897c1da7611f6cba
Publikováno v:
Acta Medica Alanya.
Objective: To evaluate the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on non-motor symptoms (NMS), sleep quality, and excessive daytime sleepiness in patients with Parkinson’s Disease (PD). Material-Method: Sixteen PD patients,
Autor:
Sehür Sibel Özkaynak, Sevda Erer, Raif Çakmur, Muhittin Cenk Akbostanci, Serhat Özkan, Bulent Elibol, Okan Dogu, Hasmet Hanagasi
Publikováno v:
Türk Nöroloji Dergisi, Vol 27, Iss 4, Pp 358-365 (2021)
Apomorphine is a dopamine agonist used in the treatment of some motor and non-motor complications during Parkinson's disease, which could be administered as an intermittent or continuous infusion. Although apomorphine treatment has been shown to be e